Trademark: AFIBROMER
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for AFIBROMER
We do not have any records of a proof of use for AFIBROMER at this moment.
Possible trademark infringements of AFIBROMER
Basic Information about AFIBROMER
- Serial Number
- 87508729
- Filing Date
- 28 Jun 2017
- Registration Number
- 6064583
- Registration Date
- 26 May 2020
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of AFIBROMER on the blockchain with WikiTrademarks.io.
- First use of AFIBROMER anywhere
- AFIBROMER was first used on 30 Jan 2018 for the primary classification of goods and services, international, 001 (Chemicals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 001
- US Codes
- 001; 005; 006; 010; 026; 046
- First use of AFIBROMER anywhere
- AFIBROMER was first used on 05 Dec 2017 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns AFIBROMER?
1. Sigilon Therapeutics, Inc. Cambridge MA
2. Sigilon Therapeutics, Inc. Cambridge MA
3. Sigilon Therapeutics, Inc. Cambridge MA
Correspondent
- John R. Rudolph
- Eli Lilly and Company
- Lilly Corporate Center
- www.lilly.com
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io